Navari - Pre-clinical study of software based AR-tool for safer cancer removal.

Purpose and goal:

In this call, Navari applied for funding with the aim of being able to test its technology in its proper environment for the first time, in a pre-clinical study. The goal was for the product to be tested by end users in its intended environment, in order to generate significant data and thus get closer to a clinical study. After completing the project, it can be stated that Navari has conducted a successful study where a Proof of Concept in vivo has been achieved.

The technology worked as intended and a large amount of valuable feedback and data has been compiled. Expected results and effects:

The project has led to Navari´s technology being tested for the first time in its intended environment, where a large amount of necessary data and feedback has been generated. This can now be used in the further development of Navari´s technology. With the completion of the study and a positive outcome in said study, a major risk element in the development of a

medical device product is completed. Navari has taken a big step closer to the market where the next major upcoming milestone is a clinical study. Approach and implementation:

The project was carried out continuously during 2023, where a large part of the work involved planning, coordinating and compiling the necessary material, equipment and documentation required to carry out the study. The study itself was conducted during weeks 37-38 at Experimental Biomedicine in Gothenburg, where Navari´s technology could be validated for the first time in the intended environment.

The data has since been analysed and compiled and will now be implemented in future product development.